A new UChicago startup is harnessing the microbiome to treat disease, thanks in part to research conducted by ITM investigator John Alverdy, MD. Alverdy’s research on the gut microbiome–the trillions of …
Lost in a mess of inconsistent and unclear research jargon? The National Center for Advancing Translational Sciences’ (NCATS), the ITM’s parent organization, can help translate. BEST (Biomarkers, EndpointS, and other …
Join the NIH and National Center for Advancing Translational Sciences (NCATS), ITM’s parent organizations, in person or via webcast at their annual Rare Disease Day on Feb. 27, 2017. Through …